Immune modulation for prevention of type 1 diabetes mellitus
I Raz, R Eldor, Y Naparstek - TRENDS in Biotechnology, 2005 - cell.com
Prevention of type 1 diabetes mellitus requires early intervention in the autoimmune process
directed against β cells of the pancreatic islets of Langerhans. This autoimmune …
directed against β cells of the pancreatic islets of Langerhans. This autoimmune …
The distinct effects of a butanol fraction of Bidens pilosa plant extract on the development of Th1-mediated diabetes and Th2-mediated airway inflammation in mice
CLT Chang, HK Kuo, SL Chang, YM Chiang… - Journal of Biomedical …, 2005 - Springer
Bidens pilosa is claimed to be useful for immune or anti-inflammatory disorders; however,
little scientific evidence has been published concerning its function. In this paper, immune …
little scientific evidence has been published concerning its function. In this paper, immune …
Antigen-specific induction of regulatory T cells for type 1 diabetes therapy
C Filippi, D Bresson, M Herrath - International reviews of …, 2005 - Taylor & Francis
Since their discovery decades ago, regulatory T (Treg) cells have prompted many
investigations into their potential role in the generation or prevention of autoimmune …
investigations into their potential role in the generation or prevention of autoimmune …
Liposome-mediated combinatorial cytokine gene therapy induces localized synergistic immunosuppression and promotes long-term survival of cardiac allografts
H Furukawa, K Oshima, T Tung, G Cui… - The Journal of …, 2005 - journals.aai.org
Localized gene transfer has the potential to introduce immunosuppressive molecules only
into the transplanted allograft, which would limit systemic side effects, and prolong allograft …
into the transplanted allograft, which would limit systemic side effects, and prolong allograft …
Gene therapy for type 1 diabetes
N Giannoukakis, M Trucco - American journal of therapeutics, 2005 - journals.lww.com
The most intensively studied autoimmune disorder, type 1 diabetes mellitus (DM1), has
attracted perhaps the greatest interest for gene-based therapeutic and prophylactic …
attracted perhaps the greatest interest for gene-based therapeutic and prophylactic …
Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus
R Eldor, IR Cohen, I Raz - International reviews of immunology, 2005 - Taylor & Francis
Type 1 diabetes mellitus is an autoimmune disease caused by a culmination of noxious
processes of autoimmunity composed of various components of the innate and adaptive …
processes of autoimmunity composed of various components of the innate and adaptive …
Terplex Gene Delivery System
SW Kim - Advances in genetics, 2005 - Elsevier
Polymeric gene delivery systems have been developed to overcome problems caused by
viral carriers. They are low cytotoxic, have no size limit, are convenient in handling, of low …
viral carriers. They are low cytotoxic, have no size limit, are convenient in handling, of low …
Targeting Antigen-Specific T Cells for Gene Therapy of Autoimmune Disease
GJ Prud'homme, JM Johnson, VK Tuohy - Gene Therapy of Autoimmune …, 2005 - Springer
One of the most exciting advances in the field of gene therapy in recent years is the
establishment of the antigen-specific T cell as a vector for the delivery of genetically-derived …
establishment of the antigen-specific T cell as a vector for the delivery of genetically-derived …
[图书][B] Use of localized gene transfer to develop novel treatment strategies for the salivary component of Sjögren's syndrome
MR Kok - 2005 - dare.uva.nl
ACADEMISCHH PROEFSCHRIFT terr verkrijging van de graad van doctor aann de
Universiteit van Amsterdam opp gezag vann de Rector Magnificus prof. mr.. PF van der …
Universiteit van Amsterdam opp gezag vann de Rector Magnificus prof. mr.. PF van der …
Gene Therapy Approaches for Autoimmune Diseases of the Central Nervous System and Other Tissues
Conclusions The gene therapy of autoimmunity has held many promises for the last ten
years, owing to its potential as an alternative therapeutic approach for diseases lacking a …
years, owing to its potential as an alternative therapeutic approach for diseases lacking a …